within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AF04_Filgotinib;

model Filgotinib
  extends Pharmacolibrary.Drugs.ATC.L.L04AF04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L04AF04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Filgotinib is an oral, selective Janus kinase 1 (JAK1) inhibitor indicated for the treatment of moderate-to-severe rheumatoid arthritis and moderately to severely active ulcerative colitis. It is approved for use in several regions, including Europe and Japan.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects, after single-dose oral administration.</p><h4>References</h4><ol><li><p>Namour, F, et al., &amp; Tasset, C (2022). Filgotinib: A Clinical Pharmacology Review. <i>Clinical pharmacokinetics</i> 61(6) 819–832. DOI:<a href=&quot;https://doi.org/10.1007/s40262-022-01129-y&quot;>10.1007/s40262-022-01129-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35637376/&quot;>https://pubmed.ncbi.nlm.nih.gov/35637376</a></p></li><li><p>Westhovens, R (2023). Filgotinib in rheumatoid arthritis. <i>Expert review of clinical immunology</i> 19(2) 135–144. DOI:<a href=&quot;https://doi.org/10.1080/1744666X.2023.2149495&quot;>10.1080/1744666X.2023.2149495</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36396615/&quot;>https://pubmed.ncbi.nlm.nih.gov/36396615</a></p></li><li><p>Anderson, K, et al., &amp; Othman, AA (2022). Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants. <i>Clinical pharmacology in drug development</i> 11(2) 235–245. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1015&quot;>10.1002/cpdd.1015</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34468080/&quot;>https://pubmed.ncbi.nlm.nih.gov/34468080</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Filgotinib;
